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Abstract 
 
This study was undertaken to evaluate the antidiarrhoeal activity of 3, 7, 4/-trihydroxy-3/-(8//-acetoxy-7//-methyloctyl)-5, 
6-dimethoxyflavone, a flavonoid isolated from the stem bark of Stereospermum kunthianum. The antidiarrhoeal activity was 
evaluated using rodent models with diarrhoea. The normal intestinal transit, castor oil-induced intestinal transit and castor oil-
induced diarrhoea tests in mice as well as castor oil-induced intestinal fluid accumulation in rats were employed in the study. The 
animals were pretreated with distilled water (10 ml/kg for mice, 5 ml/kg for rats), dimethoxyflavone (25 mg/kg or 50 mg/kg), 
morphine (10 mg/kg), or indomethacin (10 mg/kg) before induction of diarrhoea with castor oil (0.2ml for mice and 2ml for rats).  
Dimethoxyflavone dose dependently and significantly reduced (P<0.05) castor oil-induced intestinal motility.  Its antimotility 
effect at the dose of 50 mg/kg was higher compared to that of morphine (10 mg/kg). Dimethoxyflavone (25 mg/kg and 50 mg/kg) 
caused a delay in the onset of diarrhoea reduction in the number and weight of wet stools and total stools in mice with castor oil-
induced diarrhoea compared to the distilled water treated mice. Treatment with dimethoxyflavone (25 mg/kg or 50 mg/kg) did not 
produce any remarkable effect on castor oil-induced intestinal fluid accumulation in rats and normal intestinal transit in mice. The 
results indicate that dimethoxyflavone possesses antidiarrhoeal activity due to its intestinal antimotility effect and inhibition of 
other diarrhoeal pathophysiological processes. In conclusion, dimethoxyflavone reduced the frequency and severity of diarrhoea 
in the diarrhoeal models studied. 
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Introduction 
 
Diarrhoea is the leading cause of death in childhood and the frail elderly (Kosec et al., 2003). Gastrointestinal 
alterations accompanied with diarrhoea have their major impact in the developing world (WHO, 2009).  In the developed world, 
despite improvements in public health and economic wealth, the incidence of diarrhoea is not completely wiped out and continues 
to be an important clinical problem (WHO, 2009).  
Although a number of therapeutic agents have been developed for the management of diarrhoea (Keith and John, 2012), 
there is a need for the continuous search for antidiarrhoeal agents. The rural dwellers in most parts of the developing world rely on 
their indigenous medicine, usually medicinal plants for the management of diarrhoea.  Stereospermum kunthianum, a woody 
shrub of the Sudano-Guinea savannah regions of Africa and Asia, is used in the management of diarrhoea and dysentery in 
Nigeria and other West African countries (Von Maydell, 1986; Gill, 1992).  Its aqueous stem bark extract have been reported to 
possess antidiarrhoeal activity (Ching et al., 2008).   
Chromatographic fractions of the stem bark extract have also demonstrated antidiarrhoeal activity (Ching et al., 2009). 
We previously isolated, characterised and elucidated some bioactive constituents from Stereospermum kunthianum stem bark 
(Falodun et al., 2009), with analgesic and antiinflammatory activities (Ching et al., 2009).  In continuation with our efforts to 
identify the bioactive compounds that could be responsible for the reported activities from Stereospermum kunthianum stem bark, 
we isolated, characterised and elucidated an alklyated flavonoid (3,7,4/-trihydroxy-3/-(8//-acetoxy-7//-methyloctyl)-5,6-
dimethoxyflavone (Ching and Falodun, 2011).  In the present study, we report the antidiarrhoeal activity of dimethoxyflavone in 
rodents. 
 
 
Materials and Methods 
Dimethoxyflavone 
 
Dimethoxyflavone, a flavonoid previously isolated, characterised and elucidated (Ching and Falodun, 2011), was a 
yellowish powder.  
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Animals 
 
Twenty Wistar rats (140 – 150 g) and sixty Swiss mice (20 – 25 g) of either sex were used in the study. The animals 
which were maintained under standard laboratory conditions and natural 12 hours light and dark cycles had free access to standard 
chow (Bendel Feeds Plc. Ewu, Nigeria) and drinking water. The experimental protocols used in the study had the approval of the 
Animal Ethics Committee of the University of Benin, Benin City, Nigeria. Animals were handled according to the protocol 
outlined in “Principles of Laboratory Animal Care” (NIH, 1985). 
 
Drugs and chemicals 
 
The reference drugs – morphine and indomethacin – used in the study were products of the British Drug House (BDH), 
London.  Olive oil, castor oil and activated charcoal used were products of Andalucía, Spain, and were purchased from the 
Supreme Pharmacy, Benin City, Edo State, Nigeria.  
 
Effect of dimethoxyflavone on the normal intestinal transit in mice 
 
The effect of dimethoxyflavone on normal intestinal propulsion in mice was evaluated using the charcoal meal method 
(Aye-Than et al., 1989).  Overnight fasted mice of either sex were randomly allocated into four groups of 5 animals each.  Group I 
(negative control) received distilled water (10 ml/kg, p.o.), Group II received dimethoxyflavone (25 mg/kg, p.o), Group III 
received dimethoxyflavone (50 mg/kg, p.o), and Group IV (positive control) received morphine (10 mg/kg, Sc).  Thirty minutes 
later, the animals were each administered a freshly prepared standard charcoal test meal (0.2 ml of a 10% activated charcoal 
suspension in 5% gum acacia) by oral route.  After 30 minutes, the animals were sacrificed by excess chloroform inhalation. The 
small intestine was isolated and the distance traversed by the charcoal meal from the pylorus to the ileocaecal junction was 
measured.  The length of the entire small intestine was also measured. The peristaltic index for each mouse was then expressed as 
a percentage of the distance traversed by the charcoal meal relative to the total length of the small intestine. 
 
Effect of dimethoxyflavone on castor oil-induced intestinal transit in mice 
 
The method of Aye-Than et al. (1989) was used to evaluate the effect of dimethoxyflavone on castor oil-induced 
intestinal transit in mice. Thirty minutes before oral administration of castor oil (0.2 ml per mouse), four groups of mice (5 per 
group) were administered with distilled water (10 ml/kg, p.o) (negative control), dimethoxyflavone (25 mg/kg and 50 mg/kg, p.o), 
and morphine (reference drug, 10 mg/kg, Sc) respectively.  Thirty minutes, later a standard charcoal meal (0.2 ml of a 10% 
activated charcoal suspension in 5% gum acacia) was administered to each mouse by the oral route.  After thirty minutes, the 
animals were sacrificed by excess chloroform inhalation and the small intestine was isolated. The distance traversed by the 
charcoal meal from the pylorus to the ileocaecal junction was measured. The length of the entire small intestine was also 
measured. The peristaltic index for each mouse was then expressed as a percentage of the distance traversed by the charcoal meal 
relative to the total length of the small intestine. 
 
Effect of dimethoxyflavone on castor oil-induced intestinal fluid accumulation in rats 
 
The method of Robert et al. (1976) was used to evaluate the effect of dimethoxyflavone on castor oil-induced intestinal 
fluid accumulation in rats.  The animals were randomly allocated into four groups of 5 animals each. Group I (negative control) 
received distilled water (5 ml/kg, p.o), Groups II and III received dimethoxyflavone (25 mg/kg and 50 mg/kg, p.o respectively) 
and Group IV received indomethacin suspended in olive oil (10 mg/kg) orally.  One hour later, each animal received 2 mls of 
castor oil by oral route.  After One hour, the animals were sacrificed by excess chloroform inhalation.  The entire small intestine 
was isolated after ligation at the pyloric end and the ileocaecal junction respectively.  The intestinal contents were expelled into a 
graduated measuring cylinder and the volume determined.   
 
Effect of dimethoxyflavone on castor oil-induced diarrhoea in mice 
 
The method of Izzo et al. (1989) was used to evaluate the effect of dimethoxyflavone on castor oil-induced diarrhoea in 
mice.  The animals were randomly allocated into four groups of 5 animals each. Group I (control group) received distilled water 
(10 ml/kg, p.o), groups II and III received dimethoxyflavone (25mg/kg and 50 mg/kg, p.o respectively) and group IV received 
morphine (10 mg/kg, Sc).  Thirty minutes later, 0.2 ml of castor oil was orally administered to each mouse. Each mouse was 
placed under a transparent funnel, the floor of which was lined with weighed filter paper (Whatmann No. 1) and was observed for 
4 hours. The parametres observed included the onset of diarrhoea stool (first wet stool that leaves a halo on the filter paper), 
number of wet stools, weight of wet stools and total weight of faecal output. Calculations were made for the delay diarrhoea onset 
and purging index by comparison with the control group. 
 
 
Statistical analysis 
Results were analysed using the Student t-test, expressed as mean ± S.E.M and considered significant when P < 0.05. 
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Results 
 
Table 1 represents the results of the effect of dimethoxyflavone on normal intestinal transit in mice. In the negative 
control group (distilled water-treated animals), the peristaltic index was 51.00 ± 2.20. Dimethoxyflavone at the doses of 25 mg/kg 
and 50 mg/kg caused peristaltic indices of 51.65 + 4.35 and 49.43 + 6.40, respectively. These were not significantly different 
(P>0.05) from the peristaltic index of the negative control group. However, morphine (10 mg/kg) produced a peristaltic index of 
18.72 ± 4.50 which was significantly different ((P<0.05) from the negative control group (Table 1).    
 
Table 1: The effect of dimethoxyflavone on normal intestinal transit in mice 
Group Treatment CML (cm) IL (cm) Peristaltic index 
(%) 
I        Distilled water (10 ml/kg) 35.9  ± 1.26 70.6  ± 2.20 51.0  ± 2.20 
II Dimethoxyflavone (25 mg/kg) 32.8  ± 2.70 63.7  ± 1.80 51.65  ± 4.34 
III Dimethoxyflavone (50 mg/kg) 31.0  ± 1.79 64.4  ± 4.30 49.4  ± 6.40 
IV        Morphine  (10 mg/kg) 12.3  ± 2.08 66.4  ± 1.60 18.7  ± 4.50a 
Values are mean ± S.E.M of five experiments, CML = Charcoal meal length, IL = Intestinal length. aP < 0.05 significantly 
different from the distilled water-treated mice, student’s t-test. 
 
 
Table 2: Effect of dimethoxyflavone on castor oil-induced intestinal transit in mice 
Group Treatment CML (cm) IL (cm) Peristaltic 
index (%) 
Percentage 
inhibition 
I Distilled water (10 ml/kg) 24.32 ±2.40 65.5 ±2.60 37.6 ±3.62 - 
II Dimethoxyflavone (25 mg/kg) 20.6 ±3.30 69.5 ±2.90 29.8 ±4.82 20.6 
III Dimethoxyflavone (50 mg/kg) 16.1 ±2.90 71.5 ±2.80 22.2 ±3.12a 40.8 
IV Morphine  (10 mg/kg) 14.8 ±2.90 61.9 ±1.84 23.8 ±4.93 a 36.5 
Values are mean ± S.E.M of five experiments. CML = Charcoal meal length, IL = Intestinal length.  aP < 0.05 significantly 
different from the distilled water-treated mice, student’s t-test. 
 
 
Table 3: The effect of dimethoxyflavone on castor oil-induced intestinal fluid accumulation in rats  
Group Treatment Volume of intestinal 
content (ml) 
I       Distilled water (10 ml/kg) 1.28  ± 0,23 
II Dimethoxyflavone (25 mg/kg) 1.52  ± 0.24 
III Dimethoxyflavone (50 mg/kg) 1.71  ± 0.29 
IV        Morphine  (10 mg/kg) 1.16  ± 0.26 
Values are mean ± SEM of five experiments 
 
Table 4: Effect of dimethoxyflavone on castor oil-induced diarrhoea in mice 
Treatment Onset of diarrhoea 
(min) 
Number of wet 
stools 
Total number 
of stools 
Total weight of 
wet stools (g) 
Total weight 
of stools (g) 
Distilled water  
(10 ml/kg) 
33.8  ± 3.99 7.2  ± 0.96 11.6  ±1.56 0.71±0.22 0.77 ±0.11 
Dimethoxyflavone  
(25 mg/kg) 
86.8  ± 24.60 5.0  ± 1.85 11.2 ± 1.77 0.39±0.19 a 0.64 ±0.26 a 
Dimethoxyflavone 
 (50 mg/kg) 
90.5  ± 19.80 4.5  ± 2.25 9.25 ± 2.09 0.26 ±0.07a 0.69 ±0.17 a 
Morphine   
(10 mg/kg) 
0.00  ± 0.00 0.00  ± 0.00 0.00 ± 0.00 0.00±0.00 0.00 ±0.00 
Values are mean ± S.E.M of five experiments. CML = Charcoal meal length, IL = Intestinal length.  aP < 0.05 
significantly different from the distilled water-treated mice, student’s t-test. 
 
Table 2 shows the effect of the dimethoxyflavone on castor oil-induced intestinal transit in mice. The peristaltic index 
for distilled water-treated animals was 37.55 ± 3.62, while dimethoxyflavone (25 mg/kg and 50 mg/kg) had peristaltic indices of 
37.55 ± 3.62 and 22.23 ± 3.12 respectively, with percentage inhibition of castor oil-induced intestinal motilities of 20.6 and 40.8 
respectively. Morphine caused a peristaltic index of 23.84±4.93 with percentage inhibition of castor oil-induced intestinal motility 
of 36.5.   
Table 3 shows the results of the effect of dimethoxyflavone on intestinal fluid accumulation in rats. Oral administration 
of castor oil to rats pretreated with distilled water (5 ml/kg) caused intestinal fluid volume of 1.28 ± 0.23 ml. In the rats 
administered dimethoxyflavone (25 mg/kg and 50 mg/kg, orally) one hour before castor oil, the intestinal fluid volumes were 1.52 
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± 0.24 ml and 1.71 ± 0.29 ml respectively, which was not significantly different (P>0.05) from that of distilled water-treated rats. 
In the rats pretreated with indomethacin (10 mg/kg), the intestinal fluid volume was 1.16 ± 0.26 ml, which was also not 
significantly different (P>0.05) from the distilled water-treated rats.   
The results of the effect of dimethoxyflavone on castor oil-induced diarrhoea are presented in Table 4. Following castor 
oil administration, the mice pretreated with distilled water (10 ml/kg) produced diarrhoea with an onset of 33.8 ± 3.99 minutes.  
Dimethoxyflavone at the dose of 25 mg/g and 50 mg/kg administered to mice thirty minutes before the oral administration of 
castor oil caused a delay in the onset of diarrhoea (86.8 ± 24.80 and  90.5 ± 19.80 minutes), a reduction in the number of wet stool 
(5.0 ± 1.85 and 4.5 ± 2.25), total weight of wet stool (0.39 ± 0.19 and 0.26 ± 0.07g), and total weight of stool (0.64 ± 0.26 and 
0.69 ± 0.17g)  respectively when compared to the distilled water-treated mice. The mice which received morphine (10 mg/kg) did 
not produce diarrhoea stool at all. There was a significant delay (P<0.05) in the onset of diarrhoea and a significant reduction 
(P<0.05) in the total weight of wet stools in the mice which received dimethoxyflavone at the dose of 50mg/kg. There was a 
significant delay (P<0.05) in the onset of diarrhoea in the mice which received dimethoxyflavone (25 mg/kg). 
 
 
Discussion 
 
Diarrhoea is the passage of three or more loose or liquid stools per day or more frequent passage than is normal for an 
individual (WHO, 2009).  Diarrhoea is an alteration in the normal bowel movement characterised by increased frequency of 
bowel sound and movement, wet stool, and abdominal pain (Guerrant et al., 2001). Clinically, it is used to describe increased 
liquidity of stool usually associated with increased stool weight and frequency. Diarrhoea is characterised by increased active 
luminal secretion and decreased reabsorption of water and electrolytes from the lumen.  The resulting net secretion causes the 
increase in stool volume and weight. Decreased transit time and abnormal motor activities occur in patients with diarrhoea 
(Eugene, 1997).  The inhibition of experimental diarrhoea and reduction in faecal output by a substance are the basis of the 
pharmacological evaluation of a potential anti-diarrhoeal agent (Akah et al., 1999).  
The results of this study revealed that dimethoxyflavone isolated from the stem bark of Stereospermum Kunthianum 
possesses anti-diarrhoeal activity in animals with diarrhoea. Dimethoxyflavone produced no significant effect on the normal 
intestinal transit in mice. But in castor oil-induced intestinal transit in mice, dimethoxyflavone produced a dose-dependent 
decrease in distance traversed by the activated charcoal test meal, thus indicating possible antispasmodic activity. Also, 
dimethoxyflavone (50 mg/kg) produced a higher percentage inhibitory intestinal transit time effect than morphine. This may 
suggest that dimethoxyflavone at this dose may have more antispasmodic effect than morphine. This antispasmodic effect allows 
more time for water to be absorbed from faecal matter and results into better formed faecal materials. Dimethoxyflavone did not 
inhibit castor oil-induced intestinal fluid accumulation, thus suggesting that its antidiarrhoeal activity may not be related to 
antisecretory action.  Indomethacin, the reference drug used in this study, is a non-steroidal anti-inflammatory drug which has also 
been found to cause delay in onset of castor oil-induced diarrhoea and inhibit intestinal fluid secretion (Awounters et al., 1978). 
The frequency and severity of castor oil-induced diarrhoea in mice were inhibited by dimethoxyflavone. The active component of 
castor oil, ricinoleic acid, induces permeability changes in mucosal fluid and electrolyte transport that results in a hyper-secretory 
response and diarrhoea (Rajabhau et al., 2011).  Ricinoleic acid also produces irritation and inflammation of the intestinal mucosa, 
leading to release of prostaglandins, which stimulate motility and secretion. The antidiarrhoeal activity of dimethoxyflavone 
against castor oil-induced diarrhoea in mice may be attributed to an antielectrolyte permeability action. Dimethoxyflavone caused 
a delay in onset of diarrhoea and reduced the total number of stools, number of wet stools, and weight of wet stools with the 
highest effect observed at the 50 mg/kg body weight of dimethoxyflavone.  These effects were however comparatively less than 
those produced by morphine.  The antidiarrhoeal activity of flavonoids has been ascribed to their ability to inhibit intestinal 
motility and hydro-electrolytic secretions (Di Carlo et al., 1993; Di Carlo et al., 1999).  In-vitro and in-vivo experiments have 
shown that flavonoids are able to inhibit the intestinal secretory response, induced by prostaglandins E2 (Venkatesan et al., 2005). 
Dimethoxyflavone isolated from the stem bark of Stereospermum kunthianum produced antimotility effect against castor oil-
induced diarrhoea in mice. 
In conclusion, the results of this study taken together indicate that dimethoxyflavone possesses antidiarrhoeal activity. 
Although the exact mechanism of its antidiarrhoeal activity could not be established in this study, the diarrhoeal models used in 
the study show that dimethoxyflavone has antimotility activity that contributes to its antidiarrhoeal activity. 
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